Skip to main content

Boost your treatment selection

SEE WHY BIOMARKERS MATTER IN OVARIAN CANCER

A woman standing with her arms crossed

Patient portrayal.

The role of biomarkers in treatment

In ovarian cancer, biomarkers can be important when it comes to making treatment decisions, especially if the biomarkers are actionable.

An actionable biomarker is a kind of biomarker that can be targeted with medication. These medications are called targeted therapies and include PARP inhibitors, ADCs, and immunotherapies.

If you have one or more actionable biomarkers, you and your doctor may factor this in when deciding what treatment is right for you.

ADC=antibody-drug conjugate; PARP=poly(ADP-ribose) polymerase.

An illustration graphic of an IV bag and pills

ADC=antibody-drug conjugate; PARP=poly(ADP-ribose) polymerase.

Biomarkers in ovarian cancer*

BRCA1/2

(breast cancer gene 1 or 2)

How it is tested
Drawing blood or using tissue from a biopsy or surgery

Actionable result
Positive for mutation

Possible treatment type
PARP inhibitor

FRα

(folate receptor alpha)

How it is tested
Using tissue from a biopsy or surgery

Actionable result
Positive

Possible treatment type
ADC

HER2

(human epidermal growth factor receptor 2)

How it is tested
Using tissue from a biopsy or surgery

Actionable result
Positive

Possible treatment type
ADC

HRD status

(homologous recombination deficiency)

How it is tested
Using tissue from a biopsy or surgery

Actionable result
Positive

Possible treatment type
PARP inhibitor

MMR

(mismatch repair)

How it is tested
Using tissue from a biopsy or surgery

Actionable result
Deficient

Possible treatment type
Checkpoint inhibitor

MSI

(microsatellite instability)

How it is tested
Using tissue from a biopsy or surgery

Actionable result
High

Possible treatment type
Checkpoint inhibitor

*This information is current as of December 2024. Biomarkers and approved medications are frequently updated. Regularly check with your doctor about newly approved medications and testing recommendations.

An illustration graphic of two speech bubbles

Talking to your doctor about biomarkers

Discussing biomarker testing with your doctor as early as possible can be an important step in your ovarian cancer treatment journey. By asking to be tested for biomarkers, you are taking an active role in making sure you get the most appropriate treatment. 

Questions to ask your doctor:
  • Which biomarkers have I been tested for?
  • If I haven't been tested for biomarkers yet, should I be?
    • When can I be tested for any additional biomarkers?
    • How long will it take to get my results?
  • Does my cancer have any actionable biomarkers?
  • What do my biomarker results mean for treatment?
  • Am I eligible for targeted treatments? 
  • What are the next steps?